Target Validation
Confirm Target Presence and Activity
-
Confirm drug rescue effect only in models that expresses target by using Knock Out and Knock down models generated by siRNA and CRISPR
-
Measure Target Engagement Biomarkers
-
Track downstream markers of gene and protein expression by agonist-antagonist modulation of targets
Exploratory Toxicology
Find out Safe Therapeutic Range
-
Know toxicity by dose range vs general systemic response of necrosis and body weight
-
By organ specific, chronic dosage, specially toxic such as reproductive, genetic, cognitive response, hERG and endocrine
-
Poor distribution profile that leads to cytokine storm driven liver and kidney toxicity, ectopic tissue, non target migration and teratogenicity
-
Vaccine hypersensitivity, off target activity and adjuvant driven
-
Drug-drug interactions and co-morbidities or secondary metabolite driven
-
OECD Fish Tests
Test No. 203: Fish, Acute Toxicity Test
Test No. 204: Fish, Prolonged Toxicity Test: 14-Day Study
Test No. 210: Fish, Early-life Stage Toxicity Test
Test No. 212: Fish, Short-term Toxicity Test on Embryo and Sac-Fry Stages
Test No. 215: Fish, Juvenile Growth Test
Test No. 230: 21-day Fish Assay : A Short-Term Screening for Oestrogenic and Androgenic Activity, and Aromatase Inhibition
Test No. 229: Fish Short Term Reproduction Assay
Test No. 234: Fish Sexual Development Test
Test No. 236: Fish Embryo Acute Toxicity (FET) Test
Test No. 305: Bioconcentration: Flow-through Fish Test
​
Based on the profile of test candidate a toxicity evaluation path can be created.
HIT Identification
Move Superfast with Zebrafish Phenotype Rescue Screens
-
For each disease a phenotype biomarker can provide early indication of rescue potency
-
Know impact of R group on drug potency by a quick phenotype response.
-
Evaluate different compounds under multiple dilution matrix for fragment based discovery.
-
Confirm candidates with phenotype rescue through in vivo biomarker response from tissue or fluids.
In Vivo DMPK
Sort Kinetics Early on
-
Know if enough drug has reached the site of action through tissue distribution
-
Analyse Cmax, k, t1/2 elimination, cl, VD and AUC
-
Corelate pharmacodynamics and toxicokinetics from various dose effect endpoints
-
Follow human routes of administration such as oral solid, oral liquid, I.P, I.V, intrathecal, intracranial, sub-cutaneous and water dissolution
-
Clarify on Drug-Drug Interactions
In Vivo Pharmacology
Generate More evidence by measuring Clinical Endpoints in Research Models
-
Screen tests compounds in research models that are genetically similar with human disease
-
Optimize lead through phenotype rescue studies
-
Validate rescue potential with pre-clinical biomarkers of clinical evaluation
-
Chart a proof of concept through detailed functional rescue assays that show dose response
-
Show comprehensive mode of action through expression analysis, biomarkers, kinetic assays
-
Build strong visual evidence through digital pathology and IHC
Translational Research
Predict Biomarker guided Human Dose
-
Use zebrafish dose formulas to accurately predict clinical trial dose
-
Apply translation biomarkers to guide fish data replication in humans
-
Generate a closer drug target engagement by the use of Humanized In vivo pharmacology models provides
-
Replicate clinical endpoint scores & biomarkers assays in zebrafish
Biologics Testing
Move faster with Humanized Zebrafish with Better Expression
-
Express target proteins and evaluate safety and efficacy
-
Know if Anti Drug Antibodies are evoked
-
Generate immune cellular profiles after Vaccine Challenge Testing
-
Employ PROTAC screening marker for Targeted Protein Degradation
Genetic Quality & Strain Testing
Make your Most Relevant Models
-
Employ CRISPR to develop the needed allelic strains
-
Validate strains through sequencing and PCR markers
-
Confirm quality of strains through genetic tests
Xenobiotic Testing
Identify Safer and Effective Xenobiotics
-
Measure effect vs toxicity using zebrafish larvae screens
-
Know morphology, response toxicity, mixture toxicity confirmed through a wide range of metabolic markers
-
Know targeted impact on angiogenesis, and long term effect on thyrocytes and hepatocytes